Serina Therapeutics Files 2024 10-K
Ticker: SER · Form: 10-K · Filed: Mar 24, 2025 · CIK: 1708599
| Field | Detail |
|---|---|
| Company | Serina Therapeutics, Inc. (SER) |
| Form Type | 10-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
Serina Therapeutics filed its 2024 10-K. Check financials and risks.
AI Summary
Serina Therapeutics, Inc. filed its 2024 10-K on March 24, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, formerly known as AgeX Therapeutics, Inc., is involved in the pharmaceutical preparations industry. The filing details its business operations, financial statements, and risk factors. Serina Therapeutics is headquartered in Huntsville, Alabama.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Serina Therapeutics' financial health and strategic direction for the fiscal year 2024, including any significant changes or challenges.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Serina Therapeutics faces inherent risks related to drug development, regulatory approvals, market competition, and intellectual property.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
- 001-38519 — SEC File Number (SEC filing identifier)
Key Players & Entities
- Serina Therapeutics, Inc. (company) — Filer of the 10-K
- AgeX Therapeutics, Inc. (company) — Former name of Serina Therapeutics, Inc.
- 2024-12-31 (date) — Fiscal year end
- 20250324 (date) — Filing date
- Huntsville, Alabama (location) — Company headquarters
FAQ
What were Serina Therapeutics' total revenues for the fiscal year ended December 31, 2024?
The filing indicates revenue figures for License Revenue and Grant Revenues for 2024, but specific total revenue amounts are not detailed in the provided snippet.
What is the company's primary business activity?
Serina Therapeutics, Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
When did the company change its name from AgeX Therapeutics, Inc.?
The date of the name change from AgeX Therapeutics, Inc. to Serina Therapeutics, Inc. was June 6, 2017.
Where is Serina Therapeutics, Inc. located?
The company's business and mailing address is 601 Genome Way, Suite 2001, Huntsville, AL 35806.
What is the filing date of this 10-K report?
This 10-K report was filed on March 24, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 24, 2025 regarding Serina Therapeutics, Inc. (SER).